ISID Knowledge Exchange &
E-Learning Platform (IKEEP)
ISID Knowledge Exchange & E-Learning Platform (IKEEP)
The ISID Knowledge Exchange & E-Learning (IKEEP) is an online resource that shares open-access educational modules, webinars, and interactive discussions. ISID’s new online learning environment focuses on sharing evidence-based information for infectious disease management, control and prevention in resource-limited settings.
The content hosted on IKEEP serves as an enduring resource for practitioners around the globe with a focus on low- and middle-income countries. Launched in October 2020, IKEEP regularly shares critical infectious disease knowledge covering a range of global infectious disease priorities and provides content focused on career development and leadership skill-building.
Coming Soon to IKEEP
Speaker: Prof. Angela Gentile, University of Buenos Aires, Argentina
Moderators: Prof. Miguel O'Ryan, ISID Executive Committee Member, Chile & Dr. Tatiana Pinto, ISID Emerging Leader, Brazil
Abstract: El desarrollo de vacunas aceptadas que estén disponibles a escala global es una prioridad para finalizar la pandemia de COVID-19. Recientemente, hubo cambios dramáticos en la confianza de la vacuna alrededor del mundo que amenazan el éxito de las vacunas aprobadas contra COVID-19 como así también la probabilidad de lograr inmunidad de rebaño. Este seminario web incluirá una discusión en vivo y Preguntas & Respuestas sobre el estado actual de la confianza de la vacuna contra COVID-19 en América Latina, las razones de la vacilación, y propondrá caminos a seguir.
- Prof. Gagandeep Kang, ISID Executive Committee Member, India
- Global Access
- Dr. Heidi Larson, The Vaccine Confidence Project, United Kingdom
- How Vaccine Rumors Start & Why They Don’t Go Away
Moderator: Prof. Paul Tambyah, ISID President-Elect, Singapore
Abstract: The development of accepted vaccines that are available on a global scale is a priority to end the COVID-19 pandemic. Recently, there have been dramatic shifts in vaccine confidence around the world that threaten the success of approved COVID-19 vaccines as well as the likelihood of achieving herd immunity. This webinar will discuss the current state of COVID-19 vaccine confidence, reasons for hesitancy, and will propose ways forward. The need for COVID-19 vaccines is global, although the need is differentially distributed within populations. High income countries must not monopolize the global supply and every effort must be made to provide vaccines at a price affordable to low- and middle-income countries. Understanding the complexities of establishing a regionally and globally fair vaccine-allocation system are essential.
Available Content on IKEEP
Speaker: Prof. Shabir Madhi, University of Witwatersrand, South Africa
Moderator: Prof. Neelika Malavige, ISID Executive Committee Member, Sri Lanka
Abstract: Where are we with delivering safe, efficacious COVID-19 vaccines globally? What are the challenges and opportunities? This webinar provides important updates in the currently approved COVID-19 vaccines and an overview of ongoing Phase 3 trials. Attention will be paid to the vaccination of special groups such as immunocompromised individuals, children and pregnant women. We also discuss the elements required to achieve herd immunity and answer your questions about COVID-19 vaccination!
Speakers: Dr. Victor Nizet, University of California San Diego
Moderators: Prof. Marc Mendelson & Dr. Connie Walyaro
Abstract: Before the patient has even seen a doctor, their infection is already being treated by multiple antimicrobials - namely the cellular and molecular components of the innate immune system. Conventional screening paradigms in antibiotic discovery are based on MIC/MBC testing in conventional bacteriologic media, and similar tests on patient isolates are used to guide physician management. Antibiotics can synergize with endogenous antimicrobial peptides to effect bacterial killing. These studies will reveal how standard MIC testing can be misleading, overlooking potent antibiotic activities that are recognized only the context of the normal innate immune system. In this new discovery and treatment framework, drugs used in medicine for other indications (e.g. cholesterol-lowering or antiplatelet drugs), or antibiotics otherwise deemed ineffective, can be "repositioned" for treatment of multi-drug resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) or carbapenemase-resistant strains of Gram-negative pathogens including Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa.
In Collaboration with EcoHealth Alliance, Featuring:
Dr. Peter Daszak, President, EcoHealth Alliance
"Environmental Change and Emerging Infectious Diseases"
Prof. George Gao, Director-General, Chinese Center for Disease Control and Prevention
"One Health and Pandemic Preparedness in China and Beyond"
Dr. Kanta Kumari Rigaud, Lead Enviromental Specialist & Regional Climate Change Coordinayor - Africa Region, World Bank
"Climate Change, Migration, and Infectious Diseases"
Moderated by: Dr. Larry Madoff (USA) & Dr. Salma Ferchichi (Tunisia)
With generous support from the Bill & Melinda Gates Foundation, ISID presents research selected for presentation at the 19th International Congress on Infectious Diseases (ICID). This collection of ePosters reflects the contributions of early-career investigators working to advance our understanding of infectious disease challenges in low-resource settings. These studies were selected from over 1,900 abstracts due to their quality and the valuable knowledge they add to the field of infectious diseases. With topics ranging from antimicrobial resistance, disease surveillance, HIV situational assessments, metagenomics, arboviruses, and public health epidemiology, there is something to engage all interests. As you interact with these ePosters, please feel free to leave a comment or question for the researchers.
Speakers: Dr. Marjorie Pollack (USA) & Dr. Uzma Aamir (Pakistan)
Moderators: Dr. Therese Umuhoza (Kenya)
On the night of December 30, 2019, ISID’s Program for Monitoring Emerging Diseases (ProMED) Deputy Editor, Dr. Marjorie Pollack posted a request for information to the ProMED network after being contacted by a trusted colleague about a cluster of undiagnosed pneumonia cases in Wuhan, China. Through her previous experience with SARS decades earlier, Marjorie knew this new threat must be taken seriously. Luckily she sounded the alarm, and in doing so was the first to provide a detailed report alerting the international infectious diseases community to what evolved into what we now know as the global COVID-19 pandemic. With her colleague, Dr. Uzma Aamir, this webinar is an up-close and personal discussion with Marjorie, moderated by Dr. Therese Umuhoza.
Speakers: Prof. Lulu Bravo (The Philippines) & Prof. Francois Venter (South Africa)
Moderators: Prof. Alison Holmes (United Kingdom), Prof. Paul Tambyah (Singapore), Dr. Afreenish Amir (Pakistan)
Abstract: COVID-19 may have complex short- and long-term effects on global infectious disease priorities. With the world’s attention and resources focused towards COVID-19 prevention and response efforts, we are at risk of major infectious diseases making a comeback. As observed during previous crises, the indirect morbidity and mortality effects of the ongoing COVID-19 pandemic may be as important as the direct effects of the pandemic itself. There are widespread disruptions to HIV, TB and malaria service delivery programs globally with shortages in medical supplies, treatments and diagnostics. Existing programs have been hit by lockdowns, changing funding priorities and re-allocation of staff and resources. It is estimated that the disruption of routine childhood immunization services across the globe puts at least 80 million children under one at risk of vaccine-preventable diseases such as measles, mumps, rubella, polio, yellow fever, typhoid, cholera and tetanus. On the other hand, emphasis on infection prevention measures such as hand hygiene and social distancing could reduce the occurrence of community and healthcare associated infectious diseases, providing an opportunity to harness improved practices, behavior changes and attitude modifications relevant to the management of many infections. The full impact of COVID-19 on respiratory diseases and the influenza season remains unknown. Disruptions in disease surveillance and reporting further add to the complexity of understanding the true impact of COVID-19 on communicable diseases.
Featured Content Available on IKEEP
Click to access:
- COVID-19 Vaccinology Update: Development, Use, and Effect on Public Health featuring Shabir Madhi
- Collaborating with the Innate Immune System to Control Antibiotic Resistant Superbugs featuring Victor Nizet
- Emerging Infectious Diseases Preparedness - Looking Through a One Health Lens featuring Peter Daszak, George Gao, Kanta Kumari Rigaud